News & Events

Boston ONS supports oncology programs and is now offering event management packages to best suit your program needs. Check it out!

Learn More

Tue, Jan 14
Formulation Advancements in the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location is TBD
RSVP
Jan 14, 2025, 6:00 PM – 9:00 PM
Location is TBD
Wed, Jan 15
BONS Annual Meeting ~ Offering two presentations
Maggiano's Little Italy
RSVP
Jan 15, 2025, 6:30 PM – 9:00 PM
Maggiano's Little Italy, 4 Columbus Ave, Boston, MA 02116, USA
Agenda and Topics now in! Grab a seat today!
Sat, Feb 08
BONS Bookclub ~ It's back!
Zoom - coming soon
RSVP
Feb 08, 2025, 4:00 PM – 6:00 PM
Zoom - coming soon
Join Boston ONS for a virtual bookclub weekend of February 8th featuring "Between Two Kingdoms" by Suleika Jaouad
Sat, May 03
BONS Half Day Seminar
Location is TBD
RSVP
May 03, 2025, 7:30 AM – 3:00 PM
Location is TBD
We are excited to offer our Half Day Seminar in the Spring of 2025! To gauge availability, we are opening registration early to establish our contact list.

4 days ago1 min read

Boston ONS Annual Meeting ~ It's around the corner!

4 days ago0 min read

NEW EVENT! Formulation Advancements in the Treatment of mCRPC ~ Join us January 14th, 2025

Nov 26, 20241 min read

Ovarian Function Suppression in HR+ Premenopausal Advanced Breast Cancer ~ NOW December 18th, 2024

Nov 24, 20241 min read

LUNCH & LEARN ~ Advanced Systemic Mastocytosis and the APEX Clinical Trial ~ Tuesday, 12/3/24

Nov 24, 20241 min read

Elections are OPEN! Cast your vote

Nov 9, 20241 min read

Did you know? Boston ONS offers scholarships to membership

Boston ONS is proud to support its members, offering both education and conference scholarships each year. This year's application is...

Oct 31, 20241 min read

Come join the BONS Board of Directors ~ Nominations are due November 15th, 2024

Oct 31, 20241 min read

Exploring Time Off Treatment with a BCL-2 Inhibitor ~ Thursday, Nov 7th

Oct 10, 20241 min read

Recognizing the Role of TROP2 in NSCLC Management ~ Lunch Webinar offering! FREE CNEs

Oct 8, 20240 min read

FREE! Multi-Institutional Educational Symposium ~ Thursday, October 10th

Oct 8, 20241 min read

The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3

Oct 8, 20241 min read

Unlocking the Potential for a Bispecific Antibody in 3L+ DLBCL and 3L+FL ~ Wednesday, October 23rd

Oct 8, 20241 min read

Combined Power to Change the Game: RYBREVANT® + LAZCLUZE™ in First-Line Treatment of EGFR+* Locally Advanced or mNSCLC ~ Thursday, 10/24/24

Oct 4, 20241 min read

A Step Forward - Initiating VENCLEXTA Treatment in Patients with CLL - October 22nd @ 5:30pm

Sep 29, 20241 min read

Diffuse Large B Cell Lymphoma Update ~ LIVE ~ October 22nd, 6-8pm

Sep 24, 20241 min read

A Path Forward in Managing AML - NEW VIRTUAL EVENT - 10/1/24

Aug 30, 20240 min read

Updates from the Oncology Nurse Foundation

Aug 28, 20241 min read

ONS Bridge ~ Tune in live September 10 and 12

Aug 25, 20241 min read

Virtual Job Fair ~ Dana-Farber Cancer Institute ~ September 10th, 2024

Aug 25, 20241 min read

News & Events

Boston ONS supports oncology programs and is now offering event management packages to best suit your program needs. Check it out!

Boston ONS Annual Meeting ~ It's around the corner!

NEW EVENT! Formulation Advancements in the Treatment of mCRPC ~ Join us January 14th, 2025

Ovarian Function Suppression in HR+ Premenopausal Advanced Breast Cancer ~ NOW December 18th, 2024

LUNCH & LEARN ~ Advanced Systemic Mastocytosis and the APEX Clinical Trial ~ Tuesday, 12/3/24

Elections are OPEN! Cast your vote

Did you know? Boston ONS offers scholarships to membership

Come join the BONS Board of Directors ~ Nominations are due November 15th, 2024

Exploring Time Off Treatment with a BCL-2 Inhibitor ~ Thursday, Nov 7th

Recognizing the Role of TROP2 in NSCLC Management ~ Lunch Webinar offering! FREE CNEs

FREE! Multi-Institutional Educational Symposium ~ Thursday, October 10th

The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade1-3

Unlocking the Potential for a Bispecific Antibody in 3L+ DLBCL and 3L+FL ~ Wednesday, October 23rd

Combined Power to Change the Game: RYBREVANT® + LAZCLUZE™ in First-Line Treatment of EGFR+* Locally Advanced or mNSCLC ~ Thursday, 10/24/24

A Step Forward - Initiating VENCLEXTA Treatment in Patients with CLL - October 22nd @ 5:30pm

Diffuse Large B Cell Lymphoma Update ~ LIVE ~ October 22nd, 6-8pm

A Path Forward in Managing AML - NEW VIRTUAL EVENT - 10/1/24

Updates from the Oncology Nurse Foundation

ONS Bridge ~ Tune in live September 10 and 12

Virtual Job Fair ~ Dana-Farber Cancer Institute ~ September 10th, 2024

NEW EVENT! Live presentation on the latest data for Libtayo